Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 2: Identification and optimisation of substituted 2,4-bis anilino pyrimidines

被引：55

作者：

Breault, GA ^{[1
]}

Ellston, RPA ^{[1
]}

Green, S ^{[1
]}

James, SR ^{[1
]}

Jewsbury, PJ ^{[1
]}

Midgley, CJ ^{[1
]}

Pauptit, RA ^{[1
]}

Minshull, CA ^{[1
]}

Tucker, JA ^{[1
]}

Pease, JE ^{[1
]}

机构：

[1] AstraZeneca, Macclesfield SK10 4TG, Cheshire, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2003年 / 13卷 / 18期

关键词：

CELL-CYCLE; CDK4; INHIBITORS; DESIGN;

D O I：

10.1016/S0960-894X(03)00203-8

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Through chemical modification and X-ray crystallography we identified the 2,4-bis anilino pyrimidines as potent inhibitors of CDK4. Herein, we describe the optimisation of this series. (C) 2003 Elsevier Ltd. All rights reserved.

引用

页码：2961 / 2966

页数：6

共 26 条

[1] *ACC, INS 2
[2] *ACC, CNX VERS 2000 1
[3] *ACC, QUANTA2000
[4] A FAST ALGORITHM FOR RENDERING SPACE-FILLING MOLECULE PICTURES
BACON, D
ANDERSON, WF
[J]. JOURNAL OF MOLECULAR GRAPHICS, 1988, 6 (04): : 219 - 220
[5] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
BAILEY, S
[J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
[6] Cyclin D1 in breast cancer
Barnes, DM
Gillett, CE
[J]. BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 1 - 15
[7] BEATTIE JF, IN PRESS BIOORG MED
[8] BREAULT GA, Patent No. 0012485
[9] Identification of selective inhibitors of cyclin dependent kinase 4
Carini, DJ
Kaltenbach, RF
Liu, J
Benfield, PA
Boylan, J
Boisclair, M
Brizuela, L
Burton, CR
Cox, S
Grafstrom, R
Harrison, BA
Harrison, K
Akamike, E
Markwalder, JA
Nakano, Y
Seitz, SP
Sharp, DM
Trainor, GL
Sielecki, TM
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (16) : 2209 - 2211
[10] An extensively modified version of MolScript that includes greatly enhanced coloring capabilities
Esnouf, RM
[J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1997, 15 (02) : 132 - +

← 1 2 3 →